Micron Reportedly Surpasses 1 Trillion Market Cap Amid Unprecedented Support from Trump and Wall Street Ford Challenges Tesla and BYD in Europe With Electric Hatchback and SUV Expansion Plan US Productivity Growth Slows in Q4 While Labor Costs Accelerate Reports Indicate Golds Risk Premium Appears Compressed May Limit NearTerm Upside Potential Meta Broadcom and Others Launch 125 Million Semiconductor Research Hub at UCLA Obsession Poised to Achieve Major Box Office Milestones This Weekend THM Q1 2026 Earnings Modest Profit Reported Amid No Revenue and Market Pullback TOYO Q1 2026 Earnings Slight EPS Beat Fails to Lift Shares as Revenue Remains Undisclosed Maison Solutions Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges Hexcel Corporation Q1 2026 Earnings EPS Surges Past Estimates Signaling Robust Operational Efficiency HSLV Q1 2026 Earnings Massive EPS Surprise but Stock Declines KEYS Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Intuitive Surgical ISRG Drops Over 4 as Key Support Levels Tested National Storage Affiliates Trust NSA Rises Slightly as Support Holds Key Levels in Focus Dave Inc DAVE Pushes Higher Nears Key Resistance at 26907 Rocket Pharmaceuticals RCKT Posts Modest Gains as Stock Tests Key Support Levels CGI Inc GIB Edges Higher as IT Services Sector Shows Steady Momentum CNXC Q1 2026 Earnings EPS Misses Estimates as Revenue Growth Remains Uncertain LOPE Q1 2026 Earnings EPS Surpasses Estimates Stock Slips Slightly INTU Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher SGML Q1 2026 Earnings EPS Surprises to the Upside Despite Lithium Market Pressures Faraday Future Intelligent Electric FFAI Q1 2026 Earnings Narrower Loss Surprises but Revenue Remains Absent CLNN Q1 2026 Earnings Significant EPS Beat Despite PreRevenue Status and Stock Decline H1B Returnees Face Cautious AILed Job Market in India Experts Caution SPCE Q1 2026 Earnings Narrower Than Expected Loss as Company Reshapes Space Tourism Strategy Acumen Pharmaceuticals ABOS Holds Ground Near Resistance Can Biotech Momentum Continue